Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-22,216
Closed -$75.8K 520
2024
Q4
$75.8K Sell
22,216
-820
-4% -$2.36K 0.03% 347
2024
Q3
$67.7K Buy
23,036
+405
+2% +$1.33K 0.03% 431
2024
Q2
$76.9K Buy
22,631
+7,643
+51% +$25K 0.04% 422
2024
Q1
$45.4K Sell
14,988
-1,030
-6% -$3.62K 0.02% 419
2023
Q4
$67.4K Buy
16,018
+6,295
+65% +$34.1K 0.04% 422
2023
Q3
$66.4K Sell
9,723
-969
-9% -$8.56K 0.04% 391
2023
Q2
$111K Sell
10,692
-3,422
-24% -$30.6K 0.07% 342
2023
Q1
$98.4K Sell
14,114
-5,421
-28% -$47.3K 0.05% 344
2022
Q4
$118K Buy
19,535
+11,802
+153% +$87.2K 0.06% 423
2022
Q3
$61K Buy
7,733
+57
+0.7% +$665 0.02% 433
2022
Q2
$104K Buy
7,676
+3,648
+91% +$60.3K 0.04% 422
2022
Q1
$79K Sell
4,028
-230
-5% -$4.59K 0.04% 340
2021
Q4
$146K Buy
4,258
+2,108
+98% +$84.8K 0.06% 355
2021
Q3
$117K Sell
2,150
-109
-5% -$6.57K 0.05% 372
2021
Q2
$166K Sell
2,259
-221
-9% -$22.1K 0.07% 389
2021
Q1
$227K Buy
2,480
+43
+2% +$4.17K 0.1% 308
2020
Q4
$198K Buy
+2,437
New +$187K 0.08% 346

Other funds holding CVAC

Virtus ETF Advisers's CVAC Position: Q1 2025 in Review

Virtus ETF Advisers sold out of CureVac (CVAC) in Q1 2025, closing a stake of 22,216 shares — an estimated $75.8K sold.

Virtus ETF Advisers first reported a position in CVAC in Q4 2020 and held it in 17 quarters. The position peaked at $227K in Q1 2021. 83 funds tracked by Wall St. Rank hold CVAC as of Q1 2025.

  • Virtus ETF Advisers reported no remaining CureVac position as of Q1 2025 after selling out during the quarter.
  • Virtus ETF Advisers sold 22,216 CureVac shares in Q1 2025, an estimated $75.8K.
  • Virtus ETF Advisers first reported a position in CureVac in Q4 2020 and held it in 17 quarters.
  • Virtus ETF Advisers's CureVac position peaked at $227K in Q1 2021.
  • 83 funds tracked by Wall St. Rank held CureVac as of Q1 2025.

Based on Virtus ETF Advisers's 13F filing for Q1 2025, filed 14 May 2025.